NCT03112785 - Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 17, 2011

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Primary Hip OsteoarthritisSecondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory DiseaseBilateral Hip DiseaseSurgical Treatment

Interventions

DEVICE

Total hip arthroplasty (Fitmore or CLS uncemented femoral stem made by Zimmer-Biomet, Warshaw, USA)

The most symptomatic side is randomised to one of the two stem types studied. If the patient has equal amount of symptoms on both sides, the one with most pronounced degenerative Changes on plain radiographs will be randomised. On the second side the type of stem not used on the first one will be inserted. All patients and allhip will receive the same type and design of cup.